Market Cap: $12.27M
NL
NeuroSense Therapeutics Ltd.
NRSN
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $12.27M
Analysts estimated NRSN earnings of $-0.20 per share this quarter (Q2). NRSN's actual earnings were $-0.19 per share.
NRSN EPS surprise of 6.86%Analysts estimated NRSN earnings of $-0.12 per share this quarter (Q4). NRSN's actual earnings were $-0.06 per share.
NRSN EPS surprise of 48.85%Analysts estimated NRSN earnings of $-0.16 per share this quarter (Q3). NRSN's actual earnings were $-0.11 per share.
NRSN EPS surprise of 32.60%Analysts estimated NRSN earnings of $-0.20 per share this quarter (Q2). NRSN's actual earnings were $-0.02 per share.
NRSN EPS surprise of 90.20%Analysts estimated NRSN earnings of $-0.21 per share this quarter (Q1). NRSN's actual earnings were $-0.35 per share.
NRSN EPS surprise of -67.38%Analysts estimated NRSN earnings of $-0.20 per share this quarter (Q4). NRSN's actual earnings were $-0.16 per share.
NRSN EPS surprise of 27.50%Analysts estimated NRSN earnings of $-0.25 per share this quarter (Q3). NRSN's actual earnings were $0.10 per share.
NRSN EPS surprise of -140.02%